Description: Qualigen is a biotechnology company focused on developing novel products for the treatment and testing of cancer and infectious diseases. Its current commercial product is the FastPack rapid diagnostic testing system. This "Laboratory in a Pouch" is installed in physician offices, clinics and small hospitals around the world, and quickly detects diseases and medical conditions at the point-of-care. Since its inception almost 20 years ago, FastPack has generated more than $100 million in commercial sales. Qualigen's worldwide distributor for FastPack is Sekisui Diagnostics, a subsidiary of a multibillion-dollar Japanese chemical and technology company. Sekisui owns approximately 15.8% of Qualigen's outstanding common shares.
Home Page: www.qualigeninc.com
QLGN Technical Analysis
2042 Corte Del Nogal
Carlsbad,
CA
92011
United States
Phone:
760 918 9165
Officers
| Name | Title |
|---|---|
| Mr. Michael S. Poirier | Chairman & CEO |
| Ms. Amy S. Broidrick | Pres, Chief Strategy Officer & Director |
| Mr. Tariq Arshad M.B.A., M.D. | Sr. VP & Chief Medical Officer |
| Mr. Christopher L. Lotz | VP of Fin. & CFO |
| Mr. Shishir K. Sinha | COO, Corp. Sec. & Sr. VP of Diagnostics |
| Dr. Wajdi Abdul-Ahad | VP of R&D and Chief Scientific Officer |
Exchange: NASDAQ
Country: US : United States of America
Currency: US Dollar ($)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0.4921 |
| Price-to-Sales TTM: | 1.1783 |
| IPO Date: | 2015-06-24 |
| Fiscal Year End: | December |
| Full Time Employees: | 39 |